TIA1 and synucleinopathy: Plasma TIA-1 concentrations were measured in Alzheimer’s disease, mild cognitive impairment due to AD (MCI-AD), vascular cognitive impairment (VCI), and other neurodegenerative diseases (NDs: synucleinopathies and tauopathies), and compared to healthy controls.